Glomulin: A permissivity factor for vaccinia virus infection

Journal of Interferon and Cytokine Research

Volumn 32, Issue 3, 2012, Pages 127-137

  Rahbar, Ramtin ^a,b,c   Rogers, Erin ^a,b   Murooka, Thomas ^a,b   Kislinger, Thomas ^b,c   Fish, Eleanor N ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GLOMULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; T LYMPHOCYTE; VACCINIA; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS REPLICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE; GENE SILENCING; HUMANS; INDOLES; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PIPERAZINES; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-MET; SULFONAMIDES; TYROSINE; VACCINIA VIRUS;

VACCINIA VIRUS;

EID: 84857875212     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0100     Document Type: Article

References (67)

1. Ahn BY, Moss B. 1992. RNA polymerase-associated transcription specificity factor encoded by vaccinia virus. Proc Natl Acad Sci U S A 89(8):3536-3540.
2. Andrade AA, Silva PN, Pereira AC, De Sousa LP, Ferreira PC, Gazzinelli RT, Kroon EG, Ropert C, Bonjardim CA. 2004. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem J 381(Pt 2):437-446.
3. Beattie E, Kauffman EB, Martinez H, Perkus ME, Jacobs BL, Paoletti E, Tartaglia J. 1996. Host-range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes 12(1):89-94.
4. Becker Y, Joklik WK. 1964. Messenger RNA in cells infected with vaccinia virus. Proc Natl Acad Sci U S A 51:577-585.
5. Broyles SS, Yuen L, Shuman S, Moss B. 1988. Purification of a factor required for transcription of vaccinia virus early genes. J Biol Chem 263(22):10754-10760.
6. Campellone KG, Leong JM. 2005. Nck-independent actin assembly is mediated by two phosphorylated tyrosines within enteropathogenic Escherichia coli Tir. Mol Microbiol 56(2):416-432.
7. Carter GC, Rodger G, Murphy BJ, Law M, Krauss O, Hollinshead M, Smith GL. 2003. Vaccinia virus cores are transported on microtubules. J Gen Virol 84(Pt 9):2443-2458.
8. Chambraud B, Radanyi C, Camonis JH, Shazand K, Rajkowski K, Baulieu EE. 1996. FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin. J Biol Chem 271(51):32923-32929.
9. Chang HW, Watson JC, Jacobs BL. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A 89(11):4825-4829.
10. Cox B, Kotlyar M, Evangelou AI, Ignatchenko V, Ignatchenko A, Whiteley K, Jurisica I, Adamson SL, Rossant J, Kislinger T. 2009. Comparative systems biology of human and mouse as a tool to guide the modeling of human placental pathology. Mol Syst Biol 5:279.
11. Damaso CR, Moussatche N. 1998. Inhibition of vaccinia virus replication by cyclosporine A analogues correlates with their affinity for cellular cyclophilins. J Gen Virol 79 (Pt 2):339-346.
12. de Magalhaes JC, Andrade AA, Silva PN, Sousa LP, Ropert C, Ferreira PC, Kroon EG, Gazzinelli RT, Bonjardim CA. 2001. A mitogenic signal triggered at an early stage of vaccinia virus infection: Implication of MEK/ERK and protein kinase A in virus multiplication. J Biol Chem 276(42):38353-38360.
13. Drillien R, Koehren F, Kirn A. 1981. Host range deletion mutant of vaccinia virus defective in human cells. Virology 111(2):488-499.
14. Drillien R, Spehner D, Kirn A. 1978. Host range restriction of vaccinia virus in Chinese hamster ovary cells: Relationship to shutoff of protein synthesis. J Virol 28(3):843-850.
15. Earley AK, Chan WM, Ward BM. 2008. The vaccinia virus B5 protein requires A34 for efficient intracellular trafficking from the endoplasmic reticulum to the site of wrapping and incorporation into progeny virions. J Virol 82(5):2161-2169.
16. Enoch T, Nurse P. 1991. Coupling M phase and S phase: Controls maintaining the dependence of mitosis on chromosome replication. Cell 65(6):921-923.
17. Fenner F, Sambrook JF. 1966. Conditional lethal mutants of rabbitpox virus. II. Mutants (p) that fail to multiply in PK-2a cells. Virology 28(4):600-609.
18. Frischknecht F, Moreau V, Rottger S, Gonfloni S, Reckmann I, Superti-Furga G, Way M. 1999. Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature 401(6756):926-929.
19. Gemmell A, Fenner F. 1960. Genetic studies with mammalian poxviruses. III. White (u) mutants of rabbitpox virus. Virology 11:219-235.
20. Girard F, Strausfeld U, Fernandez A, Lamb NJ. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67(6):1169-1179.
21. Gortzak-Uzan L, Ignatchenko A, Evangelou AI, Agochiya M, Brown KA, St Onge P, Kireeva I, Schmitt-Ulms G, Brown TJ, Murphy J, Rosen B, Shaw P, Jurisica I, Kislinger T. 2008. A proteome resource of ovarian cancer ascites: Integrated proteomic and bioinformatic analyses to identify putative biomarkers. J Proteome Res 7(1):339-351.
22. Grisendi S, Chambraud B, Gout I, Comoglio PM, Crepaldi T. 2001. Ligand-regulated binding of FAP68 to the hepatocyte growth factor receptor. J Biol Chem 276(49):46632-46638.
23. Guerra S, Aracil M, Conde R, Bernad A, Esteban M. 2005. Wiskott-Aldrich syndrome protein is needed for vaccinia virus pathogenesis. J Virol 79(4):2133-2140.
24. Guerra S, Lopez-Fernandez LA, Pascual-Montano A, Munoz M, Harshman K, Esteban M. 2003. Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J Virol 77(11):6493-6506.
25. Hruby DE, Lynn DL, Condit RC, Kates JR. 1980. Cellular differences in the molecular mechanisms of vaccinia virus host range restriction. J Gen Virol 47(2):485-488.
26. Hruby DE, Lynn DL, Kates JR. 1979. Vaccinia virus replication requires active participation of the host cell transcriptional apparatus. Proc Natl Acad Sci U S A 76(4):1887-1890.
27. Hsiao JC, Chao CC, Young MJ, Chang YT, Cho EC, Chang W. 2006. A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells. J Virol 80(15):7714-7728.
28. Huang CY, Lu TY, Bair CH, Chang YS, Jwo JK, Chang W. 2008. A novel cellular protein, VPEF, facilitates vaccinia virus penetration into HeLa cells through fluid phase endocytosis. J Virol 82(16):7988-7999.
29. Johnston JB, McFadden G. 2003. Poxvirus immunomodulatory strategies: Current perspectives. J Virol 77(11):6093-6100.
30. Kermorgant S, Parker PJ. 2005. c-Met signalling: Spatio-temporal decisions. Cell Cycle 4(3):352-355.
31. Kermorgant S, Zicha D, Parker PJ. 2004. PKC controls HGFdependent c-Met traffic, signalling and cell migration. EMBO J 23(19):3721-3734.
32. Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A, Scott MS, Gramolini AO, Morris Q, Hallett MT, Rossant J, Hughes TR, Frey B, Emili A. 2006. Global survey of organ and organelle protein expression in mouse: Combined proteomic and transcriptomic profiling. Cell 125(1):173-186.
33. Komano J, Miyauchi K, Matsuda Z, Yamamoto N. 2004. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol Biol Cell 15(12):5197-5207.
34. Locker JK, Kuehn A, Schleich S, Rutter G, Hohenberg H, Wepf R, Griffiths G. 2000. Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV. Mol Biol Cell 11(7):2497-2511.
35. Ma PC, Jagadeeswaran R, Jagadeesh S, Tretiakova MS, Nallasura V, Fox EA, Hansen M, Schaefer E, Naoki K, Lader A, Richards W, Sugarbaker D, Husain AN, Christensen JG, Salgia R. 2005. Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer. Cancer Res 65(4):1479-1488.
36. Machesky LM, Cole NB, Moss B, Pollard TD. 1994. Vaccinia virus expresses a novel profilin with a higher affinity for polyphosphoinositides than actin. Biochemistry 33(35):10815-10824.
37. Masters J, Hinek AA, Uddin S, Platanias LC, Zeng W, McFadden G, Fish EN. 2001. Poxvirus infection rapidly activates tyrosine kinase signal transduction. J Biol Chem 276(51):48371-48375.
38. McClain ME. 1965. The host range and plaque morphology of rabbitpox virus (Rpu + ) and its U mutants on chick fibroblast, Pk-2a, and L929 cells. Aust J Exp Biol Med Sci 43:31-44.
39. McFadden G. 2005. Poxvirus tropism. Nat Rev Microbiol 3(3):201-213.
40. Morrison DK, Moyer RW. 1986. Detection of a subunit of cellular Pol II within highly purified preparations of RNA polymerase isolated from rabbit poxvirus virions. Cell 44(4):587-596.
41. Moss B. 2001. Poxviridae: The viruses and their replication. Philadelphia: Lippincott-Raven Publishers.
42. Moss B, Carroll MW, Wyatt LS, Bennink JR, Hirsch VM, Goldstein S, Elkins WR, Fuerst TR, Lifson JD, Piatak M, Restifo NP, Overwijk W, Chamberlain R, Rosenberg SA, Sutter G. 1996. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Adv Exp Med Biol 397:7-13.
43. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J 11(3):961-971.
44. Payne LG, Kristensson K. 1982. The effect of cytochalasin D and monensin on enveloped vaccinia virus release. Arch Virol 74(1):11-20.
45. Pedley S, Cooper RJ. 1984. The inhibition of HeLa cell RNA synthesis following infection with vaccinia virus. J Gen Virol 65 (Pt 10):1687-1697.
46. Perez OD, Krutzik PO, Nolan GP. 2004. Flow cytometric analysis of kinase signaling cascades. Methods Mol Biol 263:67-94.
47. Rahbar R, Murooka TT, Hinek AA, Galligan CL, Sassano A, Yu C, Srivastava K, Platanias LC, Fish EN. 2006. Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication. J Virol 80(14):7245-7259.
48. Roberts KL, Smith GL. 2008. Vaccinia virus morphogenesis and dissemination. Trends Microbiol 16(10):472-479.
49. Satheshkumar PS, Anton LC, Sanz P, Moss B. 2009. Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J Virol 83(6):2469-2479.
50. Sattler M, Pride YB, Ma P, Gramlich JL, Chu SC, Quinnan LA, Shirazian S, Liang C, Podar K, Christensen JG, Salgia R. 2003. A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase. Cancer Res 63(17):5462-5469.
51. Scaplehorn N, Holmstrom A, Moreau V, Frischknecht F, Reckmann I, Way M. 2002. Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr Biol 12(9):740-745.
52. Sodek KL, Evangelou AI, Ignatchenko A, Agochiya M, Brown TJ, Ringuette MJ, Jurisica I, Kislinger T. 2008. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Mol Biosyst 4(7):762-773.
53. Tagaya I, Kitamura T, Sano Y. 1961. A new mutant of dermovaccinia virus. Nature 192:381-382.
54. Valderrama F, Cordeiro JV, Schleich S, Frischknecht F, Way M. 2006. Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling. Science 311(5759):377-381.
55. Wali A, Strayer DS. 1996. Regulation of p53 gene expression by a poxviral transcription factor. Virology 224(1):63-72.
56. Wali A, Strayer DS. 1999a. Comparative effects of virulent and avirulent poxviruses on cell cycle progression. Exp Mol Pathol 66(1):31-38.
57. Wali A, Strayer DS. 1999b. Infection with vaccinia virus alters regulation of cell cycle progression. DNA Cell Biol 18(11):837-843.
58. Wang F, Ma Y, Barrett JW, Gao X, Loh J, Barton E, Virgin HW, McFadden G. 2004. Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat Immunol 5(12):1266-1274.
59. Wang J, Chenivesse X, Henglein B, Brechot C. 1990. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343(6258):555-557.
60. Wang J, Zindy F, Chenivesse X, Lamas E, Henglein B, Brechot C. 1992. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene 7(8):1653-1656.
61. Wang X, Le P, Liang C, Chan J, Kiewlich D, Miller T, Harris D, Sun L, Rice A, Vasile S, Blake RA, Howlett AR, Patel N, McMahon G, Lipson KE. 2003. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther 2(11):1085-1092.
62. Weisswange I, Newsome TP, Schleich S, Way M. 2009. The rate of N-WASP exchange limits the extent of ARP2/3-complexdependent actin-based motility. Nature 458(7234):87-91.
63. Welch PJ, Wang JY. 1992. Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc Natl Acad Sci U S A 89(7):3093-3097.
64. Werden SJ, Rahman MM, McFadden G. 2008. Poxvirus host range genes. Adv Virus Res 71:135-171.
65. Wilton S, Dales S. 1986. Influence of RNA polymerase II upon vaccinia virus-related translation examined by means of alpha-amanitin. Virus Res 5(4):323-341.
66. Wyatt LS, Carroll MW, Czerny CP, Merchlinsky M, Sisler JR, Moss B. 1998. Marker rescue of the host range restriction defects of modified vaccinia virus Ankara. Virology 251(2):334-342.
67. Yoo NK, Pyo CW, Kim Y, Ahn BY, Choi SY. 2008. Vaccinia virus-mediated cell cycle alteration involves inactivation of tumour suppressors associated with Brf1 and TBP. Cell Microbiol 10(3):583-5892.